KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lovesac (LOVE) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Lovesac (LOVE) over the last 9 years, with Q4 2025 value amounting to $23.7 million.

  • Lovesac's Cash & Equivalents fell 6154.71% to $23.7 million in Q4 2025 from the same period last year, while for Nov 2025 it was $23.7 million, marking a year-over-year decrease of 6154.71%. This contributed to the annual value of $83.7 million for FY2025, which is 379.38% down from last year.
  • Lovesac's Cash & Equivalents amounted to $23.7 million in Q4 2025, which was down 6154.71% from $34.2 million recorded in Q3 2025.
  • Lovesac's Cash & Equivalents' 5-year high stood at $92.4 million during Q1 2022, with a 5-year trough of $3.8 million in Q4 2022.
  • Over the past 5 years, Lovesac's median Cash & Equivalents value was $58.2 million (recorded in 2023), while the average stood at $54.1 million.
  • As far as peak fluctuations go, Lovesac's Cash & Equivalents tumbled by 9199.36% in 2022, and later surged by 88481.21% in 2023.
  • Quarter analysis of 5 years shows Lovesac's Cash & Equivalents stood at $47.9 million in 2021, then plummeted by 91.99% to $3.8 million in 2022, then skyrocketed by 884.81% to $37.7 million in 2023, then soared by 63.47% to $61.7 million in 2024, then tumbled by 61.55% to $23.7 million in 2025.
  • Its Cash & Equivalents stands at $23.7 million for Q4 2025, versus $34.2 million for Q3 2025 and $26.9 million for Q2 2025.